ID
44340
Descripción
Study ID: 110951 Clinical Study ID: 110951 Study Title: A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1995057 in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01476046 See https://clinicaltrials.gov/ct2/show/NCT01476046 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: N/A, Placebo Trade Name: N/A Study Indication: Respiratory Disorders This phase I trial primarily studies the safety and tolerability of ascending single intravenous doses of the selective TNFR1 antagonist GSK1995057 in healthy volunteers, and secondly explores the drug's pharmacodynamics, pharmacokinetics, concentration in lung epithelial lining fluid as well as its effect on immune system markers. The drug is hypothesized to be useful for Acute Lung Injury. The single-centre study consists of two parts A and B with seven cohorts/ten subcohorts in total. Part A includes ascending doses of the investigational product given to subjects negative or positive for pre-existing human anti-heavy chain variable domain (HAVH) antibodies (Cohorts 1 to 3 with Subcohorts 1a, 2a and 3a negative for HAVH and 1b, 2b, 3b positive for HAVH). Part B includes only subjects negative for HAVH, with ascending doses given to Cohorts 4 to 6. Cohort 7 receives the same dose as Cohort 6, but whereas the other Cohorts are single-blinded, Cohort 7 is open-label and additionally receives a bronchoalveolar lavage (BAL). The study consists of a Screening Visit (up to 56 days before Day 1, the day of the drug administration), Visits on Day -1, 1, 2, 3, 5, 7, 14, 28 and Follow-Up Visits on Day 57 and 85. This form is to be filled in at the end of the study (regular follow-up or study discontinuation) and lists whether any repeated/additional investigations were performed and/or whether certain events occured in the participant, such as (Non-)Serious Adverse Events. Details about the investigations/events are recorded in different forms.
Link
https://clinicaltrials.gov/ct2/show/NCT01476046
Palabras clave
Versiones (2)
- 22/10/19 22/10/19 -
- 20/9/21 20/9/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
20 de septiembre de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Phase I Trial of Intravenous TNFR1 Antagonist GSK1995057 in Healthy Subjects - NCT01476046
Logs and Repeats
- StudyEvent: ODM
Descripción
Adverse Event/Concomitant Medication/Unscheduled Assessment Check Questions
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C2347852
- UMLS CUI-3
- C3854240
- UMLS CUI-4
- C0220825
Descripción
Concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347852
Descripción
Non-serious adverse events
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1518404
Descripción
Serious adverse events
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519255
Descripción
Unscheduled ECGs
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013798
- UMLS CUI [1,2]
- C3854240
Descripción
Abnormal, clinically significant ECG
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0522055
- UMLS CUI [1,2]
- C2985739
Descripción
Unscheduled vital signs
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C3854240
Descripción
Unscheduled spirometry
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3854240
- UMLS CUI [1,2]
- C0037981
Descripción
Unscheduled pharmacokinetic samples
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3854240
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Descripción
Unscheduled Holter
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013801
- UMLS CUI [1,2]
- C3854240
Descripción
Abnormal, clinically significant Holter or Telemetry
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013801
- UMLS CUI [1,2]
- C0522055
- UMLS CUI [1,3]
- C2826293
- UMLS CUI [2,1]
- C0039451
- UMLS CUI [2,2]
- C2826293
- UMLS CUI [2,3]
- C0205161
Descripción
Unscheduled Immunogenicity
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C4054739
- UMLS CUI [1,2]
- C3854240
Descripción
Unscheduled Biomarker Serum
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3854240
- UMLS CUI [1,2]
- C0005516
- UMLS CUI [1,3]
- C0229671
Descripción
Unscheduled Biomarker Assessment from Whole Blood
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3854240
- UMLS CUI [1,2]
- C0005516
- UMLS CUI [1,3]
- C0370231
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1705236
Descripción
Liver Event
Alias
- UMLS CUI-1
- C0023884
- UMLS CUI-2
- C0877248
Descripción
If yes, please complete the Liver Event form(s).
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0023901
- UMLS CUI [1,2]
- C0008000
- UMLS CUI [1,3]
- C0587081
- UMLS CUI [1,4]
- C0243161
- UMLS CUI [1,5]
- C2746065
- UMLS CUI [1,6]
- C0304229
Similar models
Logs and Repeats
- StudyEvent: ODM
C0545082 (UMLS CUI [1,2])
C1264639 (UMLS CUI [2,1])
C1516048 (UMLS CUI [2,2])
C2347852 (UMLS CUI-2)
C3854240 (UMLS CUI-3)
C0220825 (UMLS CUI-4)
C3854240 (UMLS CUI [1,2])
C2985739 (UMLS CUI [1,2])
C3854240 (UMLS CUI [1,2])
C0037981 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
C3854240 (UMLS CUI [1,2])
C0522055 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0039451 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
C0205161 (UMLS CUI [2,3])
C3854240 (UMLS CUI [1,2])
C0005516 (UMLS CUI [1,2])
C0229671 (UMLS CUI [1,3])
C0005516 (UMLS CUI [1,2])
C0370231 (UMLS CUI [1,3])
C0008000 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,4])
C2746065 (UMLS CUI [1,5])
C0304229 (UMLS CUI [1,6])